Graft-versus-host disease natural history, complications and prognosis: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
==Prognosis== | ==Prognosis== | ||
A few different prognostic classifications have been developed for GvHD. | |||
*Johns Hopkins Hospital | |||
*Center for International Blood and Marrow Transplant Research | |||
*NIH consensus classification | |||
==References== | ==References== |
Revision as of 02:51, 18 June 2017
Graft-versus-host disease |
Differentiating Graft-versus-host disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Graft-versus-host disease natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Graft-versus-host disease natural history, complications and prognosis |
FDA on Graft-versus-host disease natural history, complications and prognosis |
CDC on Graft-versus-host disease natural history, complications and prognosis |
Graft-versus-host disease natural history, complications and prognosis in the news |
Blogs on Graft-versus-host disease natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
Natural History
Complications
Prognosis
A few different prognostic classifications have been developed for GvHD.
- Johns Hopkins Hospital
- Center for International Blood and Marrow Transplant Research
- NIH consensus classification